There were 1,294 press releases posted in the last 24 hours and 438,429 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image